Publication: 2279

Publication: 2279

Randomized Placebo-Controlled Phase II Study of Dasatinib with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma (GBM), N0877

URL

URL

Google Scholar

Citation:: J Clin Oncol vol 33 (suppl) abstr 2013

Meeting Instance:: ASCO 2015
Year:: 2015
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Nadia Laack Eva Galanis S. Keith Anderson Clinton Leinweber Jan Buckner Caterina Giannini Francois Geoffroy Derek R. Johnson Glenn J. Lesser Kurt Jaeckle Jann Sarkaria

Networks:: HEARTLAND, LAPS-MN026, NC002, NC012

Study: NCCTG-N0877
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: